IN2014CH07744A - - Google Patents

Info

Publication number
IN2014CH07744A
IN2014CH07744A IN7744CH2014A IN2014CH07744A IN 2014CH07744 A IN2014CH07744 A IN 2014CH07744A IN 7744CH2014 A IN7744CH2014 A IN 7744CH2014A IN 2014CH07744 A IN2014CH07744 A IN 2014CH07744A
Authority
IN
India
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IN2014CH07744A publication Critical patent/IN2014CH07744A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
IN7744CH2014 2012-03-21 2014-10-21 IN2014CH07744A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000062A ITFI20120062A1 (en) 2012-03-21 2012-03-21 COMPONENTS FOR THE TREATMENT OF DISEASES RELATED TO ISCHEMIA-REPERFUSION.

Publications (1)

Publication Number Publication Date
IN2014CH07744A true IN2014CH07744A (en) 2016-07-01

Family

ID=46147570

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7744CH2014 IN2014CH07744A (en) 2012-03-21 2014-10-21

Country Status (24)

Country Link
US (2) US9932352B2 (en)
EP (1) EP2855487B1 (en)
JP (2) JP6382791B2 (en)
KR (2) KR102181346B1 (en)
CN (1) CN104395321B (en)
AU (2) AU2013237021B2 (en)
CA (1) CA2907652C (en)
CY (1) CY1118282T1 (en)
DK (1) DK2855487T3 (en)
EA (1) EA033160B1 (en)
ES (1) ES2601384T3 (en)
HR (1) HRP20161436T1 (en)
HU (1) HUE031535T2 (en)
IL (1) IL234796B (en)
IN (1) IN2014CH07744A (en)
IT (1) ITFI20120062A1 (en)
LT (1) LT2855487T (en)
ME (1) ME02553B (en)
PL (1) PL2855487T3 (en)
PT (1) PT2855487T (en)
RS (1) RS55337B1 (en)
SI (1) SI2855487T1 (en)
SM (1) SMT201700055B (en)
WO (1) WO2013140348A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10531655B2 (en) 2011-12-02 2020-01-14 The Regents Of The University Of California Reperfusion protection solution and uses thereof
IT202000008125A1 (en) 2020-04-16 2021-10-16 Minerva Srl 3-AZA-BICYCLE CARBOXYLIC ACIDS [3.2.1] OCTANE AND THEIR DERIVATIVES FOR USE IN THE TREATMENT OF INFLAMMATIONS

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75910B (en) 1981-04-21 1984-08-02 Delalande Sa
EP1130022B1 (en) 2000-02-29 2009-07-22 Universita Degli Studi di Firenze 3-Aza-6,8-dioxabicyclo[3.2.1]octanes and analogues and combinatorial libraries containing them
ITFI20020107A1 (en) * 2002-06-19 2003-12-19 Antonio Guarna PHARMACEUTICAL COMPOSITIONS SUITABLE FOR USE IN THE TREATMENT OF DISEASES RELATED TO THE ACTION OF NEUTROFINS AND ACTIVE COMPOUNDS CONTAINED IN THEM
WO2004009588A1 (en) * 2002-07-18 2004-01-29 Pfizer Products Inc. Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor
WO2006015183A2 (en) * 2004-07-30 2006-02-09 Axonyx, Inc. Pharmaceutical compositions for treating disorders of the skin
ATE540957T1 (en) * 2008-11-25 2012-01-15 Univ Firenze BICYCLIC PEPTIDOMIMETICS INHIBITORS OF ASPARTYL PROTEASES FOR THE TREATMENT OF INFECTIOUS DISEASES

Also Published As

Publication number Publication date
HUE031535T2 (en) 2017-07-28
PL2855487T3 (en) 2017-02-28
ME02553B (en) 2017-02-20
EP2855487B1 (en) 2016-08-03
SI2855487T1 (en) 2017-05-31
HRP20161436T1 (en) 2017-01-13
WO2013140348A1 (en) 2013-09-26
ITFI20120062A1 (en) 2013-09-22
CN104395321B (en) 2017-05-03
KR20200049912A (en) 2020-05-08
US20180155363A1 (en) 2018-06-07
AU2013237021A1 (en) 2014-11-13
CN104395321A (en) 2015-03-04
EA033160B1 (en) 2019-09-30
AU2013237021B2 (en) 2017-08-24
LT2855487T (en) 2016-11-25
CA2907652A1 (en) 2013-09-26
AU2017265037B2 (en) 2018-03-15
DK2855487T3 (en) 2016-12-05
US20150080388A1 (en) 2015-03-19
ES2601384T3 (en) 2017-02-15
IL234796B (en) 2018-02-28
JP6382791B2 (en) 2018-08-29
EP2855487A1 (en) 2015-04-08
CY1118282T1 (en) 2017-06-28
US9932352B2 (en) 2018-04-03
KR102181346B1 (en) 2020-11-23
PT2855487T (en) 2016-12-20
EA201401045A1 (en) 2015-03-31
RS55337B1 (en) 2017-03-31
JP2015514069A (en) 2015-05-18
AU2017265037A1 (en) 2017-12-07
KR20150014910A (en) 2015-02-09
SMT201700055B (en) 2017-03-08
JP2018168173A (en) 2018-11-01
CA2907652C (en) 2021-03-16

Similar Documents

Publication Publication Date Title
BR112014017635A2 (en)
BR112014019860A2 (en)
BR112014017625A2 (en)
BR112014019889A2 (en)
BR112014017659A2 (en)
BR112014017646A2 (en)
BR112014017638A2 (en)
BR112014019610A2 (en)
AR092201A1 (en)
BR112014018910A2 (en)
BR112013027865A2 (en)
BR112014018708A2 (en)
BR112014017634A2 (en)
BR112014017673A2 (en)
BR112014017644A2 (en)
BR112014017647A2 (en)
BR112014017618A2 (en)
BR112015009304A2 (en)
BR112014017630A2 (en)
BR112014017652A2 (en)
BR112014017621A2 (en)
BR112014017627A2 (en)
BR112014017623A2 (en)
BR112014017622A2 (en)
BR112014017641A2 (en)